Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 May 27, 12:27

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting | The Manila Times

BioNTech SE
Webhose 2025 May 27, 12:18

MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, "

BioNTech SE
Webhose 2025 May 27, 07:00

AI-Driven mRNA Therapeutics Market Development Accelerated by AI Integration in Drug Design Delivery and Scalable Manufacturing

BioNTech SE
Webhose 2025 May 27, 00:00

Cambridge R&D Centre being created by BioNTech in £1bn UK spree

BioNTech SE
Webhose 2025 May 26, 09:00

2,061 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by GF Fund Management CO. LTD.

BioNTech SE
Webhose 2025 May 26, 07:21

BioNTech SE (NASDAQ:BNTX) Stake Cut by Bank of America Corp DE

BioNTech SE
Webhose 2025 May 24, 14:22

JPMorgan Chase & Co. Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech SE
Webhose 2025 May 24, 12:10

BioNTech's (BNTX) "Buy" Rating Reaffirmed at HC Wainwright

BioNTech SE
Webhose 2025 May 23, 05:58

BioNTech SE (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2025 May 21, 19:26

BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion

BioNTech SE
Webhose 2025 May 21, 10:42

BioNTech SE (NASDAQ:BNTX) Shares Sold by Voloridge Investment Management LLC

BioNTech SE
Webhose 2025 May 19, 08:58

OMERS ADMINISTRATION Corp Purchases New Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 19, 01:06

AIM Vaccine's Next-Gen mRNA Shingles Vaccine Secures Clinical Approvals in Both PRC and U.S. ,mRNA Platform Advantages Shine Through | The Manila Times

BioNTech SE
Webhose 2025 May 18, 10:44

Tema Etfs LLC Acquires New Shares in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 15, 02:06

Bank of America Securities Keeps Their Buy Rating on BioNTech SE (BNTX) | Markets Insider

BioNTech SE
Webhose 2025 May 14, 09:50

Cresset Asset Management LLC Decreases Stock Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 14, 02:00

BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term

BioNTech SE
Webhose 2025 May 12, 09:09

Crestline Management LP Takes $943,000 Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 10, 12:32

Fred Alger Management LLC Sells 35,467 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 09, 09:00

BNP Paribas Financial Markets Takes Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 08, 15:13

Morgan Stanley Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech SE
Webhose 2025 May 07, 10:45

BioNTech (BNTX) Faces Investor Concerns Amid FDA Leadership Shift | BNTX Stock News

BioNTech SE
Webhose 2025 May 07, 09:52

BioNTech (NASDAQ:BNTX) Price Target Lowered to $132.00 at Morgan Stanley

BioNTech SE
Webhose 2025 May 06, 22:35

BioNTech (BNTX) Stock Declines Amid Leadership Changes and Analyst Downgrade

BioNTech SE
Webhose 2025 May 06, 19:51

BioNTech (BNTX) Shares Tumble as FDA Announces Leadership Change

BioNTech SE
Webhose 2025 May 06, 17:36

BioNTech (BNTX): Citigroup Maintains Rating, Lowers Price Target | BNTX Stock News

BioNTech SE
Webhose 2025 May 06, 12:17

BioNTech SE (NASDAQ:BNTX) Q1 2025 Earnings Call Transcript

BioNTech SE
Webhose 2025 May 06, 11:39

Baker BROS. Advisors LP Invests $5.13 Million in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 06, 10:16

BioNTech (BNTX) Target Price Lowered by Citi Analyst Amid Quarte

BioNTech SE
Webhose 2025 May 06, 08:46

BioNTech SE (NASDAQ:BNTX) Shares Sold by Axa S.A.

BioNTech SE
Webhose 2025 May 06, 06:10

BioNTech SE (BNTX) Q1 2025 Earnings Call Highlights: Navigating Challenges and Advancing ...

BioNTech SE
Webhose 2025 May 06, 05:00

Appointments and advancements for May 6, 2025 | BioWorld

BioNTech SE
Webhose 2025 May 06, 04:25

Q1 2025 Biontech SE Earnings Call Transcript

BioNTech SE
Webhose 2025 May 05, 21:56

Health Care Down on Mixed Earnings - Health Care Roundup | Morningstar

BioNTech SE
Webhose 2025 May 05, 18:57

BioNTech (BNTX) Price Target Cut by BofA, Buy Rating Maintained | BNTX Stock News

BioNTech SE
Webhose 2025 May 05, 17:58

BioNTech (BNTX) Sees Price Target Cut Amid Upcoming Catalysts | BNTX Stock News

BioNTech SE
Webhose 2025 May 05, 12:23

BioNTech SE Appoints New CFO to Drive Financial Strategy in Oncology Expansion | BNTX stock news

BioNTech SE
Webhose 2025 May 05, 12:22

BioNTech SE (BNTX) Reports Q1 2025 Financial Results and Strategic Updates | BNTX stock news

BioNTech SE
Webhose 2025 May 05, 12:10

BioNTech says Novartis executive Zapata-Gomez to become CFO

BioNTech SE
Webhose 2025 May 05, 11:45

BioNTech (BNTX) Reveals Q1 Revenue and Advances in Strategic Focus | BNTX Stock News

BioNTech SE
Webhose 2025 May 05, 11:36

BioNTech (BNTX) Reports Q1 Loss, Maintains 2025 Financial Guidance

BioNTech SE
Webhose 2025 May 05, 11:34

BioNTech (BNTX) Welcomes Ramón Zapata-Gomez as New CFO

BioNTech SE
Webhose 2025 May 05, 11:33

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

BioNTech SE
Webhose 2025 May 05, 10:54

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update | The Manila Times

BioNTech SE
Webhose 2025 May 05, 10:45

BioNTech Reports Smaller-Than-Expected Loss, Names New CFO

BioNTech SE
Webhose 2025 May 05, 07:20

BioNTech Q1 Loss Widens, Revenues Down; Confirms FY25 Outlook

BioNTech SE
Webhose 2025 May 05, 07:00

BioNTech SE Q1 25 Earnings Conference Call At 8:00 AM ET

BioNTech SE
Webhose 2025 May 05, 00:00

BNTX Q1 2025 Earnings Report on 5/5/2025

BioNTech SE
Webhose 2025 May 02, 07:53

BioNTech SE (NASDAQ:BNTX) Shares Purchased by CANADA LIFE ASSURANCE Co

BioNTech SE
Webhose 2025 May 01, 12:09

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

BioNTech SE
Webhose 2025 May 01, 10:46

BioNTech (BNTX) Involved in New Vaccine Development Initiative | BNTX Stock News

BioNTech SE
Webhose 2025 Apr 30, 16:17

BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why

BioNTech SE
Webhose 2025 Apr 30, 15:48

Pfizer, BioNTech Fail to Void Alnylam's Covid-Shot Patent Claims

BioNTech SE
Webhose 2025 Apr 30, 09:56

BioNTech (BNTX) Projected to Post Earnings on Monday

BioNTech SE

BioNTech news

Tommy Yap 2025 Mar 04, 16:00

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Pfizer shares sink as revenue prospects
Georgy Istigechev 2023 Dec 14, 05:13

Pfizer shares sink on lower COVID revenue prospects

Shares
shutterstock_1781525795.jpg
Zachariah Walker 2023 Feb 14, 09:11

5 Stocks to Fall in Love with this Valentines Day

2021 Aug 24, 08:05

Stocks make further gains as oil bounce carries on

Latest news

Show more
Ghko B 2025 May 28, 16:00

Tariff news update: US trade court blocks Trump “liberation day” tariffs

Stocks
Frances Wang 2025 May 28, 16:00

Crypto market today: How high will Bitcoin get this year?

Cryptocurrencies
Frances Wang 2025 May 28, 16:00

Joby Stock Is Climbing Today: what’s going on with Joby Aviation?

Stocks
Tommy Yap 2025 May 28, 16:00

Morning Note: USD Jumps on Tariff Block; NVIDIA's Strong Q1; Costco Earnings Due

Morning Note Forex Tech
Frances Wang 2025 May 27, 16:00

GOOGL Share Price Analysis: Why Alphabet Stock Is Up Today?

Stocks
Frances Wang 2025 May 27, 16:00

Stock market today: Hang Seng Dips, Nikkei Gains. Dow jumps

Stocks
Tommy Yap 2025 May 27, 16:00

Morning Note: RBNZ Eases Policy; Aussie Inflation Surprises; Tesla Struggles in Europe

Morning Note
Tommy Yap 2025 May 26, 16:00

Morning Note: Gold Awaits Fed Clues; Japan Fiscal Strain; SNB Hints More Cuts

Morning Note Commodities

Info

Spread

0.7548

Spread (%)

0.7774 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

23690719232

Shares Outstanding

240392992

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.59

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.
Markets.com Bonus Trading

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot